Under the leadership of Dr. Aston, the overall goal of the data and analysis core (DAC) is to provided data management and statistical support to the Administrative Core and the individual projects of the Oklahoma SLE SCOR. The specific functions of the DAC will be: (1) to provide expertise in data acquisition and management to support in the design of questionnaires and data entry forms, (2) to design and implement appropriate databases and data management protocols, (3) to provide expertise in both experimental design and statistical analysis, and (4) to help each Project in the preparation of manuscripts, posters, and presentations of their results. In addition, the DAC will continue to provide the education in statistical analysis to the researchers and staff of the SCOR that has already been initiated by Dr. Aston and Ms. Kim. Some of the DAC?s functions are already in practice. Ms. Kim has already designed and implemented the database for Project 1 and the design of the database for the patient recruitment through the Administrative Core is nearing completion. The DAC personnel have already consulted with the PIs on each project regarding experimental design and appropriate statistical analyses for the SCOR projects. Dr. Nath provided the analyses for the preliminary data in Project 5. Beyond the SCOR, the DAC personnel have worked extensively with these researchers on many projects. Indeed, the personnel of the DAC bring a wealth of experience in a broad range of statistical methods to the SCOR, as well as experience in collaborative research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
1P50AR048940-01
Application #
6685811
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2002-09-05
Project End
2007-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Liu, Ke; Kurien, Biji T; Zimmerman, Sarah L et al. (2016) X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol 68:1290-1300
Lu, Xiaoming; Zoller, Erin E; Weirauch, Matthew T et al. (2015) Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. Am J Hum Genet 96:731-9
Kottyan, Leah C; Zoller, Erin E; Bene, Jessica et al. (2015) The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet 24:582-96
Morris, D L; Fernando, M M A; Taylor, K E et al. (2014) MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 15:210-7
Molineros, Julio E; Maiti, Amit K; Sun, Celi et al. (2013) Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet 9:e1003222
Dozmorov, Igor; Dominguez, Nicolas; Sestak, Andrea L et al. (2013) Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. PLoS One 8:e71397
Vaughn, Samuel E; Kottyan, Leah C; Munroe, Melissa E et al. (2012) Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. J Leukoc Biol 92:577-91
Hughes, Travis; Adler, Adam; Merrill, Joan T et al. (2012) Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis 71:694-9
Castillejo-López, Casimiro; Delgado-Vega, Angélica M; Wojcik, Jerome et al. (2012) Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann Rheum Dis 71:136-42
Ko, Kichul; Franek, Beverly S; Marion, Miranda et al. (2012) Genetic ancestry, serum interferon-? activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol 39:1238-40

Showing the most recent 10 out of 100 publications